3
Oct 2 (Reuters) – HKEX : * UBS GROUP AG'S LONG POSITION IN H-SHARES OF JIANGSU HENGRUI PHARMACEUTICALS DECREASES TO 4.59% ON SEPT 25 FROM 5.17% – HKEX Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)